Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.

Pulmonary arterial hypertension (PAH) is a common complication for individuals with limited systemic sclerosis (lSSc). The identification and characterization of biomarkers for lSSc-PAH should lead to less invasive screening, a better understanding of pathogenesis, and improved treatment.Forty-nine...

Full description

Bibliographic Details
Main Authors: Sarah A Pendergrass, Everett Hayes, Giuseppina Farina, Raphael Lemaire, Harrison W Farber, Michael L Whitfield, Robert Lafyatis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-08-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2923145?pdf=render